Zhang Shi-yang, Li Bao-ying, Li Xiao-li, Cheng Mei, Cai Qian, Yu Fei, Wang Wei-dong, Tan Min, Yan Guang, Hu Shi-lian, Gao Hai-qing
Key Laboratory of Cardiovascular Proteomics of Shandong Province, Department of Geriatrics, Qi-Lu Hospital of Shandong University, Jinan, Shandong Province, China.
Mol Vis. 2013 Apr 5;19:812-21. Print 2013.
Diabetic retinopathy (DR) is a leading cause of vision loss in working-age people. To retard the development and progression of retina lesions, effective therapeutic strategies directed toward key molecular targets are desired. Phlorizin is effective in treating diabetic complications, but little is known about functional protein changes that may mediate its actions. The aim of this study was to identify retinal proteomic alterations in db/db mice treated with phlorizin.
We used C57BLKS/J db/db mice as a type 2 diabetic animal model, while C57BLKS/J db/m mice were selected as the control. Phlorizin (20 mg/kg bodyweight /d) was administrated to db/db mice for ten weeks. Serum fasting blood glucose and advanced glycation end products were determined. Meanwhile, retina cell apoptosis was determined with terminal transferase dUTP nick end labeling. Isobaric tags for relative and absolute quantification and subsequent liquid chromatography-tandem mass spectrometry (LC-MS/MS) were used to identify and profile retinal proteins among control, untreated diabetic, and phlorizin-treated db/db mice. The expression of glial fibrillary acidic protein was measured in retinas using western blotting analysis.
Phlorizin treatment significantly reduced fasting blood glucose and levels of advanced glycation end products (p<0.05) and remarkably inhibited retina cell apoptosis and the expression of glial fibrillary acidic protein in the retinas of db/db mice. In addition, we identified 1,636 proteins from retina tissue in total, of which 348 proteins were differentially expressed in db/db mice compared with the controls. Only 60 proteins in the retinas of the db/db mice were found to be differentially changed following phlorizin treatment, including 33 proteins that were downregulated and 27 proteins that were upregulated. Most of these differentially changed proteins were involved in oxidative stress, apoptosis, energy metabolism, and signaling transduction.
Our study revealed the expression of proteins differentially changed after phlorizin therapy. These proteins are most likely to participate in the development and recovery of DR. Our findings help expand understanding of the mechanism underlying the onset and progression of DR, and provide novel targets for evaluating the effects of phlorizin therapy.
糖尿病视网膜病变(DR)是导致工作年龄人群视力丧失的主要原因。为延缓视网膜病变的发展和进展,需要针对关键分子靶点的有效治疗策略。根皮苷对治疗糖尿病并发症有效,但对于可能介导其作用的功能性蛋白质变化知之甚少。本研究的目的是确定用根皮苷治疗的db/db小鼠视网膜蛋白质组的改变。
我们使用C57BLKS/J db/db小鼠作为2型糖尿病动物模型,同时选择C57BLKS/J db/m小鼠作为对照。将根皮苷(20mg/kg体重/天)给予db/db小鼠,持续10周。测定血清空腹血糖和晚期糖基化终产物。同时,用末端脱氧核苷酸转移酶介导的dUTP缺口末端标记法测定视网膜细胞凋亡。使用相对和绝对定量的等压标签以及随后的液相色谱-串联质谱(LC-MS/MS)来鉴定和分析对照、未治疗的糖尿病和根皮苷治疗的db/db小鼠中的视网膜蛋白质。使用蛋白质印迹分析测量视网膜中胶质纤维酸性蛋白的表达。
根皮苷治疗显著降低了空腹血糖和晚期糖基化终产物水平(p<0.05),并显著抑制了db/db小鼠视网膜中的细胞凋亡和胶质纤维酸性蛋白的表达。此外,我们总共从视网膜组织中鉴定出1636种蛋白质,其中348种蛋白质在db/db小鼠中与对照相比差异表达。在根皮苷治疗后,db/db小鼠视网膜中仅发现60种蛋白质有差异变化,包括33种下调的蛋白质和27种上调的蛋白质。这些差异变化的蛋白质大多数参与氧化应激、细胞凋亡、能量代谢和信号转导。
我们的研究揭示了根皮苷治疗后差异变化的蛋白质表达。这些蛋白质很可能参与了DR的发展和恢复。我们的发现有助于扩展对DR发病和进展机制的理解,并为评估根皮苷治疗效果提供新的靶点。